Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents.
about
Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolidesEffects of subtherapeutic administration of antimicrobial agents to beef cattle on the prevalence of antimicrobial resistance in Campylobacter jejuni and Campylobacter hyointestinalis.Public health consequences of macrolide use in food animals: a deterministic risk assessment.Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark.Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates.In vitro activities of 47 antimicrobial agents against three Campylobacter spp. from pigs.Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compoundsIn vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agentsSusceptibility of clinical isolates of Campylobacter jejuni to sixteen antimicrobial agents.In vitro antimicrobial susceptibility, plasmid analysis, and serotyping of epidemic-associated Campylobacter jejuniCharacterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibilityClinical features of sporadic Campylobacter infections in Norway.Campylobacter enteritis in Portugal: epidemiological features and biological markers.Serotyping studies of Campylobacter from naturally colonized chickens.Antimicrobial resistance mechanisms among Campylobacter.
P2860
Q33757452-DE8F6D16-A729-4CEA-B5D8-33C0D8B1E95AQ33884622-A6BCCD43-5151-43B6-8055-A923C3484429Q34321729-60262450-57AA-45AA-AF55-489B86853640Q35138596-70CA997E-28AE-47B9-908B-E52CBD4DA458Q35539862-6FF36B8F-B25F-4A38-B740-9E6FED362E8CQ35568889-F7E1F50E-8D20-48A5-A4A9-1CF7C74B1314Q35570699-8468EEE0-6F0C-438E-8552-D1CF06D3119DQ35572652-EAC3A9DE-7A2A-42BD-957F-B86F2761D1EDQ35646065-C9C6C6A0-408C-4DD0-95AB-607A41B6E611Q35742788-CF6AF128-22E3-42E3-BF62-A569D6613239Q37274865-A29585B2-AC81-45D4-A408-B55262B10CA9Q38272526-1FCF1BD8-CE23-4189-8FAF-47825E8C867EQ40741442-A0D4441D-C142-4CE2-B3A9-12641255B735Q41507064-B60ACBFB-B349-41C2-A93E-4403B32E7FC5Q42106410-C3741E11-2E13-4EF4-BD9F-5DCBDB8092D8Q43537712-03551006-28CF-4C99-B385-080D8D0DD068
P2860
Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Susceptibility pattern of Camp ...... ifferent antimicrobial agents.
@ast
Susceptibility pattern of Camp ...... ifferent antimicrobial agents.
@en
type
label
Susceptibility pattern of Camp ...... ifferent antimicrobial agents.
@ast
Susceptibility pattern of Camp ...... ifferent antimicrobial agents.
@en
prefLabel
Susceptibility pattern of Camp ...... ifferent antimicrobial agents.
@ast
Susceptibility pattern of Camp ...... ifferent antimicrobial agents.
@en
P2093
P2860
P356
P1476
Susceptibility pattern of Camp ...... ifferent antimicrobial agents.
@en
P2093
P2860
P304
P356
10.1128/AAC.21.6.990
P407
P577
1982-06-01T00:00:00Z